Rafferty Asset Management, LLC Chimerix Inc Transaction History

Rafferty Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.34 - $5.34 $343,704 - $1.37 Million	-256,496 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.58 - $6.8 $100,141 - $148,682	21,865 Added 9.32%	256,496 $1.18 Million
Q4 2021 Feb 10, 2022	BUY	$5.23 - $7.18 $561,173 - $770,406	107,299 Added 84.27%	234,631 $1.51 Million
Q3 2021 Nov 10, 2021	BUY	$5.94 - $8.75 $124,116 - $182,831	20,895 Added 19.63%	127,332 $788,000
Q2 2021 Aug 10, 2021	SELL	$7.54 - $9.79 $162,351 - $210,798	-21,532 Reduced 16.83%	106,437 $851,000
Q1 2021 May 10, 2021	BUY	$4.76 - $11.25 $609,132 - $1.44 Million	127,969 New	127,969 $1.23 Million

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.